Asian Hedge Fund Manager, Long Short Equity, Macro

David Mudd

Cross Asset Strategy

<ul>
<li>HK Alpha portfolio gained 3.45% in August, outperforming its benchmark by 2.67%.  Since inception, the portfolio has outperformed HK indexes by 60% to 84%. HK ALPHA is up 14.35% YTD.</li>
<li>The Sharpe ratio stands at 1.21, compared with a benchmark of 0.68 since inception.  This higher Sharpe ratio is driven by excess alpha, which represents more than 50% of returns.</li>
<li>The portfolio gained in the healthcare, industrial, and technology sectors in August, while utilities and telecom exposure dragged on performance.</li>
</ul>


HK Alpha portfolio gained 3.45% in August, outperforming its benchmark by 2.67%.  Since inception, the portfolio has outperformed HK indexes by 60% to 84%. HK ALPHA is up 14.35% YTD.
The Sharpe ratio stands at 1.21, compared with a benchmark of 0.68 since inception.  This higher Sharpe ratio is driven by excess alpha, which represents more than 50% of returns.
The portfolio gained in the healthcare, industrial, and technology sectors in August, while utilities and telecom exposure dragged on performance.


Pan-Asia Catalysts/Events, Quiddity Advisors

David Blennerhassett

Pan-Asia Catalysts/Events

Quiddity Advisors

Event-Driven

<ul>
<li>Investors see value in <a href="https://www.smartkarma.com/entities/toyota-industries-corp" target="_blank" data-smartkarma-citation="entities:4500:1" rel="noopener">Toyota Industries (6201 JP)</a>. Many are concerned TICO and TM will deliberately engage in bad corporate governance to punish minorities if the Offer doesn't go through.</li>
<li>It's doubtful an international tribunal has the clout to overturn <a href="https://www.smartkarma.com/entities/ck-hutchison-holdings-ltd" target="_blank" data-smartkarma-citation="entities:132:1" rel="noopener">CKH (1 HK)</a>'s Supreme Court decision. The safe takeaway here is that this entire construct won't be concluded anytime soon.</li>
<li>
<a href="https://www.smartkarma.com/entities/melco-international-development-ltd" target="_blank" data-smartkarma-citation="entities:809:1" rel="noopener">Melco International Development (200 HK)</a>'s divergence with <a href="https://www.smartkarma.com/entities/melco-crown-entertainme-adr" target="_blank" data-smartkarma-citation="entities:810:1" rel="noopener">Melco Resorts &amp; Entertainment (MLCO US)</a> is a curious thing. Is a statutory merger in the wings?</li>
</ul>


Investors see value in Toyota Industries (6201 JP). Many are concerned TICO and TM will deliberately engage in bad corporate governance to punish minorities if the Offer doesn't go through.
It's doubtful an international tribunal has the clout to overturn CKH (1 HK)'s Supreme Court decision. The safe takeaway here is that this entire construct won't be concluded anytime soon.

Melco International Development (200 HK)'s divergence with Melco Resorts &amp; Entertainment (MLCO US) is a curious thing. Is a statutory merger in the wings?


Last Week In Event SPACE: CKH, Toyota Industries, Melco, Rio/Glencore, Guoco

<ul>
<li>It was a sure bet Panama's highest court would annul <a href="https://www.smartkarma.com/entities/ck-hutchison-holdings-ltd" target="_blank" data-smartkarma-citation="entities:132:1" rel="noopener">CK Hutchison Holdings (1 HK)</a>'s  Panama Ports Company (PPC) port contracts. Less clear are the next steps. </li>
<li>The Panamanian government has tapped <a href="https://www.smartkarma.com/entities/ap-moeller-maersk-a-s" target="_blank" data-smartkarma-citation="entities:22428:1" rel="noopener">AP Moeller - Maersk A/S (MAERSKB DC)</a>'s APM Terminals as the temporary administrator - or "neutral stabiliser" - via a phased handover of the ports.</li>
<li>PPC has already indicated it will seek a "clarification" of the ruling. And CKH can still sue the Republic of Panama in international tribunals.</li>
</ul>


It was a sure bet Panama's highest court would annul CK Hutchison Holdings (1 HK)'s  Panama Ports Company (PPC) port contracts. Less clear are the next steps. 
The Panamanian government has tapped AP Moeller - Maersk A/S (MAERSKB DC)'s APM Terminals as the temporary administrator - or "neutral stabiliser" - via a phased handover of the ports.
PPC has already indicated it will seek a "clarification" of the ruling. And CKH can still sue the Republic of Panama in international tribunals.


CKH (1 HK): The Courts (Predictably) Annul The Panama Concessions. Now What?

<ul>
<li>The Hong Kong market continues to show gains on the back of a strong July.  The standout sectors this month include materials and healthcare.</li>
<li>Since the bottom of its bear market, Hong Kong has continued to outperform most Asian markets, even though its valuation remains well below that of others in the region.</li>
<li>
<a href="https://www.smartkarma.com/entities/sichuan-kelun-biotech-biopharmaceutical-co-ltd-class-h" target="_blank" data-smartkarma-citation="entities:40071:1" rel="noopener">Sichuan Kelun-Biotech Biopharmaceutical (6990 HK)</a> was rated a BUY by several analysts, including UBS and JPM, after 1H26 earnings announcement, benefiting from its partnership with <a href="https://www.smartkarma.com/entities/merck-co-inc" target="_blank" data-smartkarma-citation="entities:1130:1" rel="noopener">Merck &amp; Co (MRK US).</a>
</li>
</ul>


The Hong Kong market continues to show gains on the back of a strong July.  The standout sectors this month include materials and healthcare.
Since the bottom of its bear market, Hong Kong has continued to outperform most Asian markets, even though its valuation remains well below that of others in the region.

Sichuan Kelun-Biotech Biopharmaceutical (6990 HK) was rated a BUY by several analysts, including UBS and JPM, after 1H26 earnings announcement, benefiting from its partnership with Merck &amp; Co (MRK US).



BUY/SELL/HOLD: Hong Kong Market Update (August 2026)

<ul>
<li>Kalon is unlikely to overbid KKR for <a href="https://www.smartkarma.com/entities/mandom-corp" target="_blank" data-smartkarma-citation="entities:8353:1" rel="noopener">Mandom (4917 JP)</a>. KKR is unlikely to walk despite the earnings guidance revision after the DD.  ¥3,100+ is a fine place to sell.</li>
<li>Panama’s Supreme Court dings <a href="https://www.smartkarma.com/entities/ck-hutchison-holdings-ltd" target="_blank" data-smartkarma-citation="entities:132:1" rel="noopener">CK Hutchison (1 HK)</a>'s port concessions. CKH/Beijing won't go down without a fight; and rejigging a deal for the remaining ports will (likely) be perennially delayed.</li>
<li>
<a href="https://www.smartkarma.com/entities/hisamitsu-pharmaceutical-co" target="_blank" data-smartkarma-citation="entities:17008:1" rel="noopener">Hisamitsu Pharmaceutical Co (4530 JP)</a>is trading through terms. The family Tender Offer is light, but it likely has enormous crossholder support. They could still claim majority of minority.</li>
</ul>


Kalon is unlikely to overbid KKR for Mandom (4917 JP). KKR is unlikely to walk despite the earnings guidance revision after the DD.  ¥3,100+ is a fine place to sell.
Panama’s Supreme Court dings CK Hutchison (1 HK)'s port concessions. CKH/Beijing won't go down without a fight; and rejigging a deal for the remaining ports will (likely) be perennially delayed.

Hisamitsu Pharmaceutical Co (4530 JP)is trading through terms. The family Tender Offer is light, but it likely has enormous crossholder support. They could still claim majority of minority.


Last Week In Event SPACE: CK Hutchison, Hisamitsu Pharma, JCNC, Mandom, Sunny Optical, Rio

Hong Kong

CK Hutchison is a multinational conglomerate with core businesses in ports and related services, retail, infrastructure, and telecommunications, operating across over 50 countries. The company's diverse portfolio includes global port operations, health and beauty retail through AS Watson, and investments in energy, transportation, and mobile telecommunications. It was formed in March 2015 and is headquartered in Hong Kong.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

CK Hutchison (1 HK)

HONG KONG ALPHA PORTFOLIO: (August 2026)

HK Alpha portfolio gained 3.45% in August, outperforming its benchmark by 2.67%. Since inception, the portfolio has outperformed HK indexes by 60%...

David Mudd

Last Week In Event SPACE: CKH, Toyota Industries, Melco, Rio/Glencore, Guoco

It’s Sunday! Pour yourself a coffee, grab a comfortable seat, and sift through a brief summary of insights on various events discussed during the...

David Blennerhassett

CKH (1 HK): The Courts (Predictably) Annul The Panama Concessions. Now What?

At a ~48% NAV discount and forward P/B of 0.44x, CKH is not expensive. I see this court decision getting bureaucratically tangled. Near term,...

David Blennerhassett

BUY/SELL/HOLD: Hong Kong Market Update (August 2026)

The Hong Kong market continues to show gains on the back of a strong July. The standout sectors this month include materials and healthcare.

David Mudd

Last Week In Event SPACE: CK Hutchison, Hisamitsu Pharma, JCNC, Mandom, Sunny Optical, Rio

It’s Sunday! Pour yourself a coffee, grab a comfortable seat, and sift through a brief summary of insights on various events discussed during the...

David Blennerhassett

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)